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T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
c o r r e s p o n d e n c e
Off-Pump or On-Pump Coronary-Artery Bypass Grafting
To the Editor: In the CABG Off or On Pump 
Revascularization Study (CORONARY) described 
by Lamy et al. (March 28 issue),1 the investigators 
used the approach of an expertise-based, random-
ized, controlled trial.2 The qualified surgeons 
were those with more than 2 years of experience 
after residency training who had completed more 
than 100 cases of the specific technique. Lamy 
and colleagues also emphasized that “trainees 
were not allowed to be the primary surgeon.”
But the authors do not specify who harvested 
saphenous-vein grafts. In many centers, trainees 
are the primary surgeons for this procedure. Graft 
harvesting is an important part of the coronary-
artery bypass grafting (CABG) operation. One 
study showed that rates of vein-graft failure were 
higher among patients with poor-quality grafts, 
and vein-graft failure was associated with repeat 
revascularization.3
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To the Editor: Diegeler et al. (March 28 issue)1 
found no superiority of the off-pump CABG tech-
nique over the on-pump technique in an elderly 
population. The number of crossovers in this study 
highlights how frequently the initial surgical plan 
changes.
To address this issue, the authors performed 
an intention-to-treat analysis to evaluate the ef-
fect of treatment assignment and a per-protocol 
analysis (excluding the patients who crossed over 
from the assigned treatment). However, these types 
of analyses, which evaluate the results according 
to treatment assignment or adherence to the 
protocol, are not the best way to assess outcome, 
because CABG is a treatment that is either per-
formed or not performed; this situation is not 
analogous to prescribing a medication over the 
long term, with uncertainty regarding the pa-
tient’s compliance with the assigned treatment.
In our view, the authors should have presented 
an “as-treated” analysis based on the operation 
actually performed, and the patients who crossed 
over from the assigned treatment should not 
have been excluded.
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To the Editor: The article by Diegeler et al. 
comparing outcomes after on-pump CABG with 
outcomes after off-pump CABG once again shows 
that off-pump CABG is an excellent therapy.
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However, the statement by Diegeler and col-
leagues that “technical details were left to the 
discretion of the operating surgeon” is disappoint-
ing, since no information was provided on impor-
tant details that may have affected early results. 
The guidelines on myocardial revascularization 
published by the European Society of Cardiology 
and the European Association for Cardio-Thoracic 
Surgery recommend intraoperative graft assess-
ment,1 since it is known that surgical revision may 
be necessary in certain cases. Such assessment is 
not mentioned. In addition, antithrombotic man-
agement is not reported. In our view, this lack of 
standardization in the off-pump CABG group is a 
limitation and may explain why repeat revascular-
ization was the only significant difference reported 
between the two groups (1.3% with off-pump 
CABG vs. 0.4% with on-pump CABG).
Finally, despite the fact that 37 high-risk pa-
tients crossed over to off-pump CABG because 
of a calcified ascending aorta, the stroke rate was 
still high among patients who underwent off-
pump CABG (2.2%). It is established that system-
atic application of “anaortic” techniques (i.e., off-
pump CABG without aortic manipulation) reduces 
the rate of stroke to less than 1%,2-4 but no infor-
mation about aortic management was provided.
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To the Editor: Diegeler et al. state: “Our trial 
does not support the assumption that off-pump 
CABG can improve the early outcome in high-
risk patients.” In this statement, the authors 
overlook the fact that the rates of death in their 
study (2.6% among the patients who underwent 
off-pump CABG and 2.8% among the patients 
who underwent on-pump CABG at 30 days) are 
much lower than the rates of death among pa-
tients in the off-pump group that were predicted 
by the two risk scores used (8.3% according to 
the European System for Cardiac Operative Risk 
Evaluation [euroSCORE]1 and 3.8% according to 
the German coronary score2).
The euroSCORE is based on 18 independent 
risk variables, not all of which were specifically 
reported in the study by Diegeler et al. In our 
opinion, the reported variables suggest that the 
patients in the study were not at high operative 
risk. Among the patients in the off-pump group, 
only 1.9% were in critical condition, 2.2% had a 
creatinine level greater than 2.3 mg per deciliter 
(203.3 μmol per liter), 2.1% had a left ventricular 
ejection fraction that was less than 30%, 3.7% 
had class IV angina according to the Canadian 
Cardiovascular Society scale (ranging from I to 
IV, with higher classes indicating greater limita-
tions on physical activity owing to angina), 0.9% 
received renal-replacement therapy, and only 
3.3% had pulmonary arterial hypertension.
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To the Editor: Two trials of off-pump CABG con-
firm its lack of superiority over on-pump CABG and 
provide support for skepticism about its role.1 Sub-
tle benefits — fewer transfusions and possibly 
fewer strokes — have been shown in some studies 
by experts, but they are scanty in less experienced 
hands except in highly specific situations. Patients 
in studies with less carefully selected surgeons re-
quire more repeat revascularizations.2
In the accompanying editorial, Alexander3 
discusses the “learning curve” for the use of off-
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pump CABG and suggests limiting its use “to 
surgeons who are experienced with off-pump 
techniques.” But experienced surgeons come 
from inexperienced ones, and it is patients who 
are subject to the learning curve. When im-
proved surgical procedures replace outdated 
ones, the disparities between the results with 
expert surgeons as compared with inexpert sur-
geons are unavoidable, but what if the new tech-
nique has minimal, if any, advantages?
On-pump CABG is a refined, extensively prov-
en approach performed by vast numbers of expe-
rienced surgeons. Nevertheless, the use of off-
pump CABG remains widespread and is marketed 
aggressively to a demanding public. Considering 
the difficulty in gaining supervised experience 
after residency training, can inexperienced sur-
geons justify seeking expertise in off-pump CABG 
while subjecting patients to a learning curve?
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Dr. Lamy and Colleagues Reply: We agree 
with Sun and Wang on the importance of the 
performance of surgical trials by expert sur-
geons to avoid potential biases toward the easiest 
or most frequently performed surgical technique. 
CORONARY is an expertise-based, randomized 
trial, and the test of expertise at the beginning of 
the trial (2 years of experience after residency 
training and completion of more than 100 cases 
of the specific technique) was directed to the sur-
geons performing the operations in view of the 
magnitude of their involvement and the effect of 
their skills on the surgery. Other members of the 
operating team, such as anesthetists, perfusion-
ists, vein harvesters, and nursing staff on the 
ward, also played an important role in the care of 
patients, but they were not subjected to the same 
expertise test. However, all 79 centers that partici-
pated in our trial were large cardiac centers with 
experience in both techniques, and they perform 
hundreds of CABG procedures every year. There-
fore, it seems unlikely that a potential bias related 
to the vein harvesting or the performance of other 
team members could be introduced and could 
have influenced the results of our trial.
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Dr. Diegeler and Colleagues Reply: Saeed et 
al. correctly stated that mortality among patients 
in our trial was lower than that predicted by the 
applied risk scores. This finding does not contra-
dict the increased operative risk of the study 
population. The rationale for including patients 
75 years of age or older was that there is a higher 
risk of adverse events and consequently a higher 
event rate among these patients. This inclusion 
criterion allowed the definition of a distinct and 
large enough patient sample. When grouped ac-
cording to German coronary score quartiles, the 
frequency of the primary end point (a composite 
of death or a major adverse event within 30 days 
and within 12 months after surgery) across all 
quartiles was similar between patients who un-
derwent on-pump CABG and those who under-
went off-pump CABG (Table 1).
We share some of the objections raised by 
Sanfilippo et al. regarding the intention-to-treat 
analysis of a surgical procedure, yet the proposed 
“as-treated” analysis including the patients who 
crossed over is not adequate and would introduce 
substantial bias. Given the increased event rate 
among patients who crossed over from the as-
signed treatment,1,2 such an approach would 
blame the competing procedure (notably on-
pump CABG) for the failure of the other.
The comments by Emmert and Salzberg point 
to the area of conflict between the feasibility of 
investigating a complex procedure in a multi-
center trial and the control of every factor that 
could potentially influence the outcome. Given 
that there is no generally established “best” 
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technique and that centers and surgeons were 
selected because of their experience, details 
about antithrombotic management and flow 
measurement were indeed left to the discretion 
of each surgeon and center. When the group of 
patients assigned to off-pump CABG was divided 
according to the use or nonuse of aortic manipu-
lation (255 patients underwent the procedure 
with the anaortic technique, 277 with an anasto-
motic device, and 655 with partial aortic occlu-
sion (clamping), rates of stroke were similar in 
each group (2.4% with the anaortic technique, 
1.8% with the anastomotic device, and 2.3% 
with clamping.
Bonchek asks whether it is justified to put 
patients at risk while gaining expertise in off-
pump CABG without a proven benefit of the 
procedure. Avoidance of a “learning curve” is a 
challenge for clinical researchers, especially in 
the surgical arena. We now know that off-pump 
CABG has excellent results when performed by 
expert surgeons. If studies showed a benefit of 
off-pump CABG performed by expert surgeons, 
the consequence would be that all other sur-
geons would need to follow and adapt the off-
pump technique with all necessary efforts for 
training under a strict quality control. The aim 
of randomized trials is to investigate whether or 
not there is a need for a paradigm change.
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The Editorialist Replies: Bonchek raises an 
important point about how a person gains expe-
rience in either off-pump or on-pump CABG sur-
gery. Training in new surgical techniques that do 
not provide a proven benefit, such as the off-
pump CABG technique, should ideally be con-
ducted in established training programs that 
provide appropriate oversight and supervision 
from experienced surgeons. This is probably true 
not only for off-pump CABG surgery but for oth-
er procedures as well.
Data from empirical research are currently 
lacking on the experience necessary to both de-
velop and maintain expertise in cardiac and 
other surgical procedures.
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Table 1. Frequency of the Composite Primary End Point, According to 








no. of patients/total no. (%)
Quartile 1 12/296 (4.1) 10/272 (3.7) 0.95 (0.46–1.99)
Quartile 2 24/314 (7.6) 21/322 (6.5) 0.84 (0.46–1.53)
Quartile 3 22/287 (7.7) 21/307 (6.8) 0.85 (0.47–1.55)
Quartile 4 41/310 (13.2) 41/286 (14.3) 1.12 (0.70–1.78)
* German coronary scores range from 0 to 100, with higher scores indicating 
greater risk. CABG denotes coronary-artery bypass grafting, and CI confidence 
interval.
Progressive Multifocal Leukoencephalopathy  
Associated with Ruxolitinib
To the Editor: Ruxolitinib, an inhibitor of Janus 
kinases (JAKs) 1 and 2, has been approved in the 
United States and Europe for the treatment of 
myelofibrosis.1 We report a case of progressive 
multifocal leukoencephalopathy (PML) in a pa-
tient with myelofibrosis after initiation of ruxoli-
tinib therapy.
A 75-year-old man with intermediate-2–risk 
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